Clinical Trials Browser

Phase 1/2 × rocakinogene sifuplasmid × Head & Neck × Clear all

NCT02163057 2021-01-22

Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma

Phase 1/2 Completed

22 enrolled 14 charts

Head and Neck Squamous Cell Cancer